KEGG   DRUG: Dinutuximab
Entry
D10559                      Drug                                   
Name
Dinutuximab (USAN/INN);
Dinutuximab (genetical recombination) (JAN);
Unituxin (TN)
Product
Sequence
(Heavy chain)
EVQLLQSGPE LEKPGASVMI SCKASGSSFT GYNMNWVRQN IGKSLEWIGA IDPYYGGTSY
NQKFKGRATL TVDKSSSTAY MHLKSLTSED SAVYYCVSGM EYWGQGTSVT VSSASTKGPS
VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS
VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL LGGPSVFLFP
PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS
VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS REEMTKNQVS
LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS
CSVMHEALHN HYTQKSLSLS PGK
(Light chain)
EIVMTQSPAT LSVSPGERAT LSCRSSQSLV HRNGNTYLHW YLQKPGQSPK LLIHKVSNRF
SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YFCSQSTHVP PLTFGAGTKL ELKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
(Disulfide bridge: H22-H96, H140-H196, H216-L220, H222-H'222, H225-H'225, H257-H317, H363-H421, H'22-H'96, H'140-H'196, H'216-L'220, H'257-H'317, H'363-H'421, L23-L93, L140-L200, L'23-L'93, L'140-L'200)
  Type
Peptide
Remark
Therapeutic category: 4291
ATC code: L01FX06
Product: D10559<JP/US>
Efficacy
Antineoplastic, Immunomodulator, Anti-GD2 antibody
  Disease
Neuroblastoma [DS:H02301]
  Type
Monoclonal antibody
Target
GD2 [GL:G00114]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    L01FX Other monoclonal antibodies and antibody drug conjugates
     L01FX06 Dinutuximab beta
      D10559  Dinutuximab (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Monoclonal Antibody/Antibody-Drug Conjugate
   Dinutuximab
    D10559  Dinutuximab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D10559  Dinutuximab (USAN/INN); Dinutuximab (genetical recombination) (JAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10559
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10559
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10559
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10559
Pharmacogenomic biomarkers [br08341.html]
 Somatic variations in targeted cancer therapies
  D10559
Other DBs
CAS: 1363687-32-4
PubChem: 254741521

» Japanese version   » Back

DBGET integrated database retrieval system